ZVRA

Conviction 55HealthcareScan · Mon, Aug 10, 2026

ZVRA$11.48-0.74%

ResistanceSupportVol 14Insider sell

Vol MA14 1.83M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ZEVRA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.zevra.com ↗

Price11.48

Change-0.74%

Gap-0.35%

Rel volume1.38×

Avg volume1.55M

Avg $ vol16.73M

SMA 2011.23

SMA 5012.24

SMA 20010.11

Price vs 50-6.27%

Price vs 200+13.55%

MA stackmixed

50/200 cross—

Supertrendup · 9.41

RSI (14)50

MACD hist0.14

MACD crossbull · 2d

Stoch %K / %D69 / 71

ADX (14)28

+DI / −DI28 / 23

RSI divergenceBullish

MACD divergenceBullish

ATR %+6.22%

ADR %5.14%

52w high14.75

52w low7.23

From 52w high-22.20%

Above 52w low+58.71%

New 52w highNo

SqueezeOff

Bollinger width46.23%

%B0.55

Donchian pos56.15%

Donchian high13.33

Donchian low9.10

AVWAP (52w high)11.39

vs AVWAP high+0.75%

AVWAP (52w low)10.30

vs AVWAP low+11.39%

OBV trendDown

Chaikin MF (20)0.14

Today vs 20d1.38×

Avg vol (14d)1.83M

Avg vol (20d)1.55M

Avg $ vol (20d)16.73M

Market cap681.43M

RS 3m (vs SPY)-0.61%

RS 6m (vs SPY)+24.16%

RS line new highNo

Trend template6/8

Technical rank60.3

1 week+14.12%

1 month-14.04%

3 months+3.10%

6 months+33.43%

1 year-5.40%

YTD+37.59%

P/E8.19

P/B3.13

P/S—

P/FCF-280.08

EPS1.35

Div yield—

ROE38.24%

ROA27.49%

Debt/Eq0.00

Current5.17

EV/EBITDA-9.10

Gross margin—

Net margin—

Rev growth—

EPS growth178.88%

Price target25.25

Target upside120.04%

Analyst ratingBuy

Institutional76.27%

Ent. value536.11M

Revenue0

Net income8.75M

Gross profit—

Free cash flow-2.43M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out59.12M

Employees61

ListedThu, Apr 16, 2015

Free float56.14M

Float %95.0%

Short interest7.8M

Days to cover5.4d

Short volume51.9%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.25 vs $0.08

Last surprise+212.5% beat

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank60.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance14.81

Support9.22

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZVRA

All disclosures →

No recent disclosed trades by Congress in ZVRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZVRA · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
FAVORITO TAMARA A Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Anderson Thomas Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Calder Douglas W Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Secor Alicia Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Shih Alvin Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Watton Corey Michael Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Sangiovanni Timothy J. SVP, Finance & Corp Controller · Stock Option (right to buy) · 2026-05-28	Grant	40K	$0	2026-05-28	2026-05-29
Sangiovanni Timothy J. SVP, Finance & Corp Controller · Restricted Stock Unit · 2026-05-28	Grant	20K	$0	2026-05-28	2026-05-29
Thompson Rahsaan Chief Legal & Compliance · Common Stock · 2026-05-11	Sell	1.79K	$20K	2026-05-11	2026-05-13

SEC filings

EDGAR filings in ZVRA · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.